Literature DB >> 21585557

From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.

Marta Galach1, Jochen Utikal.   

Abstract

Induced pluripotent stem cells (iPSCs) can be generated from different somatic cell types through ectopic expression of a set of transcription factors. iPSCs acquire all the features of embryonic stem cells (ESCs) including pluripotency and can thus give rise to any cell type of the body. iPSCs comparable with ESCs are amenable for the correction of gene mutations by homologous recombination. Patient-derived iPSCs may thus be an ideal source for studying diseases in vitro and for treating different disorders in the clinic. In this review, we summarize recent advances and possibilities of iPSC research with focus on the field of dermatology.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21585557     DOI： 10.1111/j.1600-0625.2011.01282.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN： 0906-6705            Impact factor:   3.960


  11 in total

Review 1.  Molecular physiognomies and applications of adipose-derived stem cells.

Authors:  F Uzbas; I D May; A M Parisi; S K Thompson; A Kaya; A D Perkins; E Memili
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

Review 2.  Genetics and epigenetics of the skin meet deep sequence.

Authors:  Jeffrey B Cheng; Raymond J Cho
Journal:  J Invest Dermatol       Date:  2012-01-12       Impact factor: 8.551

3.  Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent.

Authors:  Justin Lowenthal; Scott Lipnick; Mahendra Rao; Sara Chandros Hull
Journal:  Stem Cells Transl Med       Date:  2012-05-08       Impact factor: 6.940

Review 4.  Toward Combined Cell and Gene Therapy for Genodermatoses.

Authors:  Laura De Rosa; Maria Carmela Latella; Alessia Secone Seconetti; Cecilia Cattelani; Johann W Bauer; Sergio Bondanza; Michele De Luca
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-05-01       Impact factor: 10.005

5.  Control of Oxidative Stress and Generation of Induced Pluripotent Stem Cell-like Cells by Jun Dimerization Protein 2.

Authors:  Shyh-Shin Chiou; Sophie Sheng-Wen Wang; Deng-Chyang Wu; Ying-Chu Lin; Li-Pin Kao; Kung-Kai Kuo; Chun-Chieh Wu; Chee-Yin Chai; Cheng-Lung Steve Lin; Cheng-Yi Lee; Yu-Mei Liao; Kenly Wuputra; Ya-Han Yang; Shin-Wei Wang; Chia-Chen Ku; Yukio Nakamura; Shigeo Saito; Hitomi Hasegawa; Naoto Yamaguchi; Hiroyuki Miyoshi; Chang-Sheng Lin; Richard Eckner; Kazunari K Yokoyama
Journal:  Cancers (Basel)       Date:  2013-07-26       Impact factor: 6.639

6.  A comparative study of osteogenic differentiation human induced pluripotent stem cells and adipose tissue derived mesenchymal stem cells.

Authors:  Abdolreza Ardeshirylajimi; Masoud Soleimani; Saman Hosseinkhani; Kazem Parivar; Parichehr Yaghmaei
Journal:  Cell J       Date:  2014-10-04       Impact factor: 2.479

7.  hiPS-MSCs differentiation towards fibroblasts on a 3D ECM mimicking scaffold.

Authors:  Ruodan Xu; Mehmet Berat Taskin; Marina Rubert; Dror Seliktar; Flemming Besenbacher; Menglin Chen
Journal:  Sci Rep       Date:  2015-02-16       Impact factor: 4.379

8.  Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response.

Authors:  Mathias Bernhardt; Daniel Novak; Yassen Assenov; Elias Orouji; Nathalie Knappe; Kasia Weina; Maike Reith; Lionel Larribere; Christoffer Gebhardt; Christoph Plass; Viktor Umansky; Jochen Utikal
Journal:  Stem Cell Reports       Date:  2017-04-06       Impact factor: 7.765

9.  Human amniotic epithelial cell feeder layers maintain iPS cell pluripotency by inhibiting endogenous DNA methyltransferase 1.

Authors:  Qing Chen; Chaolin Qiu; Yongyi Huang; Lizhen Jiang; Qin Huang; Lihe Guo; Te Liu
Journal:  Exp Ther Med       Date:  2013-09-02       Impact factor: 2.447

10.  An RNAi Screen Reveals an Essential Role for HIPK4 in Human Skin Epithelial Differentiation from iPSCs.

Authors:  Lionel Larribère; Marta Galach; Daniel Novak; Karla Arévalo; Hans Christian Volz; Hans-Jürgen Stark; Petra Boukamp; Michael Boutros; Jochen Utikal
Journal:  Stem Cell Reports       Date:  2017-09-28       Impact factor: 7.765
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.